Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serotype-specific replicating AAV helper constructs increase recombinant AAV type 2 vector production.

Chengwen Li1, R Jude Samulski

  • 1Gene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27510, USA.

Virology
|April 13, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of U2AF1 Pathogenic Variants on Prognosis of Myelodysplastic Neoplasms With RUNX1 Mutation.

Hematological oncology·2026
Same author

Enantioselective construction of polychiral helical compounds via dynamic kinetic resolution.

Nature communications·2026
Same author

Patients' Knowledge, Attitudes, and Practices Regarding Non-pharmacological Treatments for Irritable Bowel Syndrome.

Journal of neurogastroenterology and motility·2026
Same author

Optimization of a MWCNTs-AuNPs composite-modified electrochemical immunosensor with anti-fouling property for highly sensitive and rapid detection of BNP in myocardial infarction-induced heart failure diagnosis.

Bioelectrochemistry (Amsterdam, Netherlands)·2026
Same author

Sex-Related Differences in Clinical Features, Inflammatory Cytokines, Mutation Topography, Outcomes, and Prognostic Models in Patients With Myeloproliferative Neoplasms.

American journal of hematology·2026
Same author

Development of a Novel Anti-Siglec-15 Antibody for Tumor Immunotherapy.

ImmunoTargets and therapy·2025
Same journal

Viral diversity in predatory insects used for biological control: Insights from a multi-country meta-viromic analysis.

Virology·2026
Same journal

Unveiling the hidden virome of Sclerotinia sclerotiorum: New tools and discoveries in mycovirus detection.

Virology·2026
Same journal

ASFV pDP238L negatively regulates type I interferon production via inhibiting the methylation of TBK1.

Virology·2026
Same journal

Divergent poxvirus identified in a non-native black rat from Madagascar.

Virology·2026
Same journal

Genomic and functional characterization of Bacillus phage BCE1 targeting a key gut bacterium in Aedes albopictus larvae.

Virology·2026
Same journal

Viral etiology of orogenital papillomatosis and squamous cell carcinoma in bottlenose dolphins in the southeastern United States.

Virology·2026
See all related articles

This study introduces a novel method to amplify adeno-associated virus (AAV) helper functions, significantly increasing AAV vector yield for gene therapy research. This approach enhances virus production without generating replication-competent AAV, overcoming a key limitation in AAV-based therapies.

Area of Science:

  • Molecular Biology
  • Gene Therapy
  • Virology

Background:

  • Adeno-associated virus (AAV) is a crucial tool for gene therapy.
  • Current methods face limitations in producing sufficient AAV quantities for trials.
  • High AAV vector yield is essential for pre-clinical and clinical applications.

Purpose of the Study:

  • To develop a novel approach for amplifying AAV helper functions.
  • To achieve high-yield production of AAV vectors.
  • To overcome limitations in current AAV production methods.

Main Methods:

  • Cotransfection of replicating, non-packaging AAV helper constructs with adenovirus (Ad).
  • Utilizing a novel helper DNA replication system.
  • Optimization of transfection ratios for enhanced vector yield.

Related Experiment Videos

Main Results:

  • Achieved approximately 20-fold higher AAV2/GFP vector yield compared to traditional methods.
  • Demonstrated that virus yield correlates with capsid protein production.
  • Obtained an additional 2-fold increase in vector yield through transfection ratio optimization without replication-competent AAV.

Conclusions:

  • The novel helper function amplification strategy significantly boosts AAV vector production.
  • This method provides a high yield of AAV vectors without helper virus encapsidation.
  • The developed strategy supports the advancement of AAV packaging systems for gene therapy.